Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
Andrew H KoDivision of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA Abstract: Nanoliposomal irinotecan (nal-IRI) was originally developed using an efficient and high-loading capacity system to encapsulate irinot...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/61e14410da944e19b127ec1591f51a3c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|